moclobemide has been researched along with Idiopathic Parkinson Disease in 6 studies
Moclobemide: A reversible inhibitor of monoamine oxidase type A; (RIMA); (see MONOAMINE OXIDASE INHIBITORS) that has antidepressive properties.
moclobemide : A member of the class of benzamides that is benzamide substituted by a chloro group at position 4 and a 2-(morpholin-4-yl)ethyl group at the nitrogen atom. It acts as a reversible monoamine oxidase inhibitor and is used in the treatment of depression.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (83.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Distinto, S | 1 |
| Yáñez, M | 1 |
| Alcaro, S | 1 |
| Cardia, MC | 1 |
| Gaspari, M | 1 |
| Sanna, ML | 1 |
| Meleddu, R | 1 |
| Ortuso, F | 1 |
| Kirchmair, J | 1 |
| Markt, P | 1 |
| Bolasco, A | 1 |
| Wolber, G | 1 |
| Secci, D | 1 |
| Maccioni, E | 1 |
| Sieradzan, K | 1 |
| Channon, S | 1 |
| Ramponi, C | 1 |
| Stern, GM | 1 |
| Lees, AJ | 1 |
| Youdim, MB | 1 |
| Illi, A | 1 |
| Sundberg, S | 1 |
| Ojala-Karlsson, P | 1 |
| Scheinin, M | 1 |
| Gordin, A | 1 |
| Ruggieri, S | 1 |
| Fabbrini, G | 1 |
| Bramante, L | 1 |
| DePandis, F | 1 |
| Stocchi, F | 1 |
| Barbanti, P | 1 |
| Vacca, L | 1 |
| Manfredi, M | 1 |
| Steur, EN | 1 |
| Ballering, LA | 2 |
| Jansen Steur, EN | 1 |
5 trials available for moclobemide and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
The therapeutic potential of moclobemide, a reversible selective monoamine oxidase A inhibitor in Parkinson's disease.
Topics: Adult; Affect; Aged; Aged, 80 and over; Antiparkinson Agents; Benserazide; Benzamides; Cognition; Dr | 1995 |
Simultaneous inhibition of catechol-O-methyltransferase and monoamine oxidase A: effects on hemodynamics and catecholamine metabolism in healthy volunteers.
Topics: Administration, Oral; Adult; Analysis of Variance; Antidepressive Agents; Antiparkinson Agents; Benz | 1996 |
An open study with reversible MAO-A inhibitors in complicated Parkinson's disease.
Topics: Antiparkinson Agents; Benzamides; Dopamine Agonists; Drug Therapy, Combination; Humans; Levodopa; Mi | 1996 |
Moclobemide and selegeline in the treatment of depression in Parkinson's disease.
Topics: Antidepressive Agents; Benzamides; Depressive Disorder; Humans; Moclobemide; Monoamine Oxidase Inhib | 1997 |
Combined and selective monoamine oxidase inhibition in the treatment of depression in Parkinson's disease.
Topics: Adult; Aged; Benzamides; Cognition; Depression; Drug Combinations; Female; Humans; Male; Medical Rec | 1999 |
1 other study available for moclobemide and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Synthesis and biological assessment of novel 2-thiazolylhydrazones and computational analysis of their recognition by monoamine oxidase B.
Topics: Binding Sites; Humans; Hydrazones; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Dyn | 2012 |